- Hormone replacement therapy for oestrogen deficiency symptoms in postmenopausal women. - Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.
Hormone replacement therapy for estrogen deficiency symptoms in postmenopausal women.
Continuous combined hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women with intact uterus and with at least 12 months since last menses. The experience in treating women older than 65 years is limited.
Background: Aiming at partly controlled asthma (PCa) instead of controlled asthma (Ca) might decrease asthma medication use. Biomarkers, such as the fraction of exhaled nitric oxide (Feno), allow further tailoring of treatment.
Hormone replacement therapy for oestrogen deficiency symptoms in postmenopausal women with an intact uterus.
Teleflex Incorporated a leading global provider of medical technologies announced the FDA has cleared the QuikClot Control+ Hemostatic Device to include mild and moderate bleeding in cardiac surgical procedures and bone surface bleeding following a sternotomy